SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-053945
Filing Date
2021-11-03
Accepted
2021-11-03 16:08:01
Documents
14
Period of Report
2021-11-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tcon-8k_20211103.htm   iXBRL 8-K 42743
2 EX-99.1 tcon-ex991_24.htm EX-99.1 98513
3 GRAPHIC g3jrzof2hdor000001.jpg GRAPHIC 12142
  Complete submission text file 0001564590-21-053945.txt   298333

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA tcon-20211103.xsd EX-101.SCH 5701
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tcon-20211103_lab.xml EX-101.LAB 19335
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tcon-20211103_pre.xml EX-101.PRE 11498
7 EXTRACTED XBRL INSTANCE DOCUMENT tcon-8k_20211103_htm.xml XML 3564
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Filer) CIK: 0001394319 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36818 | Film No.: 211375382
SIC: 2836 Biological Products, (No Diagnostic Substances)